CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 35,794	$ 31,167
Marketable securities	52,995	73,944
Accounts receivable, net	22,692	12,103
Inventories	11,928	10,380
Research and development tax credit receivable	1,293	1,322
Prepaid expenses and other current assets	11,333	5,286
Total current assets	136,035	134,202
Property and equipment, net	526	585
Operating lease right-of-use assets	2,374	2,591
Goodwill	16,836	16,836
Research and development tax credit receivable	360	332
Other non-current assets	11,768	10,152
Total assets	167,899	164,698
Current liabilities:
Current portion of operating lease liability	953	934
Accounts payable	18,961	11,433
Accrued expenses	27,642	24,227
Other current liabilities	252	261
Total current liabilities	47,808	36,855
Long-term operating lease liability	1,449	1,690
Royalty financing obligation	34,333	32,760
Other non-current liabilities	5,925	5,654
Total liabilities	89,515	76,959
Shareholders’ equity:
Preferred shares, nominal value of $0.01 per share; $50,000 shares authorized; zero issued and outstanding at March 31, 2024 and $5,194 issued and outstanding at December 31, 2023	0	52
Ordinary shares, nominal value of $0.01 per share; $500,000 shares authorized; $96,097 issued and outstanding at March 31, 2024 and $89,825 issued and outstanding at December 31, 2023	960	898
Additional paid-in capital	874,018	855,452
Accumulated deficit	(772,838)	(745,496)
Accumulated other comprehensive loss	(23,756)	(23,167)
Total shareholders’ equity	78,384	87,739
Total liabilities and shareholders’ equity	$ 167,899	$ 164,698